RecruitingNot ApplicableNCT07537036

Analgesic Efficacy of Quadro-Iliac Plane Block Versus Erector Spinae Plane in Total Hip Arthroplasty

Analgesic Efficacy of Quadro-Iliac Plane Block Versus Erector Spinae Plane in Total Hip Arthroplasty: A Randomized Non-Inferiority Trial


Sponsor

Tanta University

Enrollment

76 participants

Start Date

Apr 18, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare the Quadro-Iliac Plane Block versus Erector Spinae Plane Block after total hip arthroplasty.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥ 18 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) physical status I-III.
  • Undergoing total hip arthroplasty (THA) under spinal anesthesia.

Exclusion Criteria9

  • History of allergies to local anesthetics.
  • Opioid dependency.
  • Body mass index (BMI) > 35 kg/m2.
  • Cognitive impairment.
  • Bleeding or coagulation disorders.
  • Psychiatric and neurological disorder.
  • Local infection at the site of injection.
  • Severe heart, lung, liver, and renal dysfunction.
  • Emergency surgery.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuadro-iliac plane block

Patients will receive ipsilateral Quadro-iliac plane block (QIPB) using 20ml of bupivacaine 0.25%.

OTHERErector spinae plane block

Patients will receive ipsilateral erector spinae plane block (ESPB) using 20ml of bupivacaine 0.25%.


Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07537036


Related Trials